about
Lapatinib for treatment of advanced or metastasized breast cancer: systematic review.Modelling the force of infection for hepatitis A in an urban population-based survey: a comparison of transmission patterns in Brazilian macro-regions.Polio inactivated vaccine costs into routine childhood immunization in Brazil.Annual national direct and indirect cost estimates of the prevention and treatment of cervical cancer in Brazil.Methods and challenges for the health impact assessment of vaccination programs in Latin AmericaA critical analysis of studies assessing L-ornithine-L-aspartate (LOLA) in hepatic encephalopathy treatment.Cross-cultural adaptation of the CDC Worksite Health ScoreCard questionnaire into Portuguese.Health technology assessment (HTA) organizations: dimensions of the institutional and political framework.Quality of life evaluation of frail elderly in Campinas, São Paulo.Healthcare resource utilization and costs of outpatient follow-up after liver transplantation in a university hospital in São Paulo, Brazil: cost description study.Hospitalization rates for pneumococcal disease in Brazil, 2004 - 2006.The Brazilian Portuguese version of the Work Productivity and Activity Impairment: General Health (WPAI-GH) Questionnaire.Cost-effectiveness analysis on spinal anesthesia versus local anesthesia plus sedation for loop colostomy closure.Challenges of interpreting epidemiologic surveillance pertussis data with changing diagnostic and immunization practices: the case of the state of São Paulo, Brazil.Systematic Review of Health Economic Evaluation Studies Developed in Brazil from 1980 to 2013.Análise de decisão multicritério para alocação de recursos e avaliação de tecnologias em saúde: tão longe e tão perto?As autoras respondemLimiares de custo-efetividade e o Sistema Único de SaúdeQualidade de vida de gestantes infectadas pelo vírus da imunodeficiência humana (HIV) na cidade de São PauloCustos dos mutirões de mamografia de 2005 e 2006 na Direção Regional de Saúde de Marília, São Paulo, BrasilInterchangeability and substitution of biosimilars: is health technology assessment (HTA) a tool for decision-making?Integrated care pathway for rectal cancer treatment: cross-sectional post-implementation study using a logic model framework
P50
Q33532659-ACDE2A87-3F96-4C88-BB44-978228F743F3Q33638085-362C76DF-7ABE-4DB4-8E01-7B2B7D7D5044Q33638085-5E461B32-6FE8-4D39-A6A9-806C7B453A1AQ35281764-BAE4B499-D94D-49EB-9382-7673C37855E7Q35565207-66B421E2-8A5B-4FEB-8409-55E5D4C09360Q36395006-69F75602-D797-41A8-B2F5-C463E268710CQ37634029-C57B8B02-274E-4C25-95EF-97C972D8E093Q38867087-10ACA8A3-8604-4E11-B34A-DFF745E5D457Q39003717-C8E4C425-1781-404D-8273-D8278A4344DBQ40279569-B1D6DE18-F991-48C8-9A51-75A52171EB3AQ40873477-2705D28A-9835-4FF8-AFC3-B8C98E1A2A4EQ43962541-9B212399-3710-4F4F-AE08-4E2780CF6FF6Q47807147-F3C157F2-3829-4F63-9E8F-5BAF4DB8385AQ48334241-CF7F0BCC-4562-429B-AAA3-D9256CFD15FBQ51783871-72E54E58-8A10-49D3-B5F1-AEBECB768262Q54981045-789E50DB-2C35-4685-BA44-3E08CF0BF815Q60669483-6B442629-B245-4DDB-8987-0209CBCB00F0Q60669484-38D8BF47-2220-4846-BF75-CE0212E0E1F7Q60669486-8D929F58-9F1D-4B70-A71F-8C40B1D2BCE5Q60669515-1C91042B-6AEA-4362-BFBA-FED9009E85CAQ60669524-E8C6A392-C64B-487B-B31E-5FE52D84DDAFQ90153431-3C31ABD1-63D1-47A6-97B4-FAC51137E25AQ92654295-E810DD53-F3A2-4D1E-952E-95818FA5916E
P50
description
hulumtuese
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Patricia Coelho de Soárez
@ast
Patricia Coelho de Soárez
@en
Patricia Coelho de Soárez
@es
Patricia Coelho de Soárez
@nl
Patricia Coelho de Soárez
@sl
type
label
Patricia Coelho de Soárez
@ast
Patricia Coelho de Soárez
@en
Patricia Coelho de Soárez
@es
Patricia Coelho de Soárez
@nl
Patricia Coelho de Soárez
@sl
altLabel
Patricia Coelho de Soárez
@en
prefLabel
Patricia Coelho de Soárez
@ast
Patricia Coelho de Soárez
@en
Patricia Coelho de Soárez
@es
Patricia Coelho de Soárez
@nl
Patricia Coelho de Soárez
@sl
P1053
D-9710-2012
P106
P1153
16038936100
P21
P31
P3829
P496
0000-0001-8383-0728